San Antonio, TX – According to filings with the U.S. Securities and Exchange Commission, Vascular Perfusion Solutions is raising $2,500,000.00 in new funding. Sources indicate as part of senior management President, Tom Debrooke played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Vascular Perfusion Solutions

Vascular Perfusion Solutions, Inc. is a development and early-stage company, formed for the purpose of commercializing new, unique, and innovative Oxygenated Perfusion Solutions for the body’s limbs, appendages, and vascularized tissues. Right now, many organs are rejected because they can’t reach patients in time. By doubling the viability of organs from 4 hours to 8 hours, more organs will be available for transplant, and more lives will be saved. The VP.S ENCORE device, which is about the size of a small coffee carafe, fits into the overhead bin of any commercial airliner. This allows VP.S ENCORE to efficiently transport organs worldwide, and thus dominate the preservation, resuscitation, and transport market.

To learn more about Vascular Perfusion Solutions, visit http://www.vascularperfusion.solutions/

Contact:
Tom Debrooke, President
210-977-0191
https://www.linkedin.com/in/tomdebrooke/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved